AR intracellular trafficking in prostate cancer
AR intracellular trafficking in prostate cancer
批准号:
6916128
负责人:
Zhou Wang
金额:
$26.12万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2010-03-31
关键词:
SDS polyacrylamide gel electrophoresisandrogen receptorbinding proteinsbiological signal transductioncell growth regulationchimeric proteinsgreen fluorescent proteinsheat shock proteinsimmunocytochemistryimmunoprecipitationintracellular transportlaboratory mousemicroinjectionsmolecular cloningneoplastic growthnuclear transportprostate neoplasmsprotein protein interactiontissue /cell culturetransfection /expression vectorwestern blottingsyeast two hybrid system
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our long-term objective is to elucidate the mechanism of androgen-independent growth of prostate cancer. Ligand-independent nuclear localization of the androgen receptor (AR) is essential in androgen-independent growth. In androgen-sensitive prostate cancer cells, AR is localized to the cytoplasm in the absence of ligand and translocates to the nucleus in the presence of ligand. In contrast, in androgen-refractory prostate cancer cells, AR is localized to the nucleus even in the absence of ligand. These observations led to our hypothesis that the nuclear export signal (NES-AR) is inactive or no longer dominant over the nuclear import signal (NLS), NL1, in the absence of ligand in androgen-refractory prostate cancer cells. Our preliminary studies have identified nuclear export signal (NES-AR) in the ligand-binding domain (LBD). NES-AR is dominant over NL1, located in the DMA-binding domain (DBD) and hinge region, in the absence of ligand. Androgen binding to LBD represses NES-AR. Interestingly, NES-AR-mediated nuclear export is modulated by heat shock protein 90 (HSP90). Five specific aims are proposed to further characterize NES-AR. 1. Confirm that NES causes nuclear export. GST-GFP-NES-AR fusion protein will be microinjected into the nuclei to test directly that NES-AR is a nuclear export signal instead of a cytoplasmic retention signal.
2. Identify amino acid residues in NES-AR that are necessary for the nuclear export and/or inhibition of the NL1 in the absence of ligand. Deletion and linker-scanning substitution mutagenesis will be employed to define the functionally important amino acid residues in NES.
3. Test the hypothesis that NES-AR is inactive or no longer dominant over NL1 in the absence of ligand in androgen-refractory prostate cancer cells. AR-positive androgen-refractory prostate cancer cells in culture and xenograft tumors will be used as models. 4. Identify and characterize proteins that bind to NES-AR. Yeast 2-hybrid screening of a human prostate cDNA library has identified 4 candidate NES-AR-binding proteins. Gain- and loss-of-function analysis will be carried out to determine their roles in the NES-AR-mediated nuclear export. 5. Characterize the role of HSP90 in NES-AR action. We will test if HSP90 directly interacts with NES-AR and/or influences the nuclear export machinery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structural and functional analysis of a novel class of androgen receptor antagonists
-
批准号:10650956
-
项目类别:
-
资助金额:$14.97万
-
财政年份:2023
-
负责人:Zhou Wang
-
依托单位:
Role of E-Cadherin Down-Regulation in Prostatic Inflammation and Lower Urinary Tract Dysfunction
-
批准号:10564514
-
项目类别:
-
资助金额:$53.66万
-
财政年份:2023
-
负责人:Zhou Wang
-
依托单位:
Targeting androgen receptor nuclear localization in prostate cancer
-
批准号:10642683
-
项目类别:
-
资助金额:$36.7万
-
财政年份:2022
-
负责人:Zhou Wang
-
依托单位:
University of Pittsburgh O'Brien Cooperative Research Center Program
-
批准号:9230541
-
项目类别:
-
资助金额:$152.55万
-
财政年份:2016
-
负责人:Zhou Wang
-
依托单位:
University of Pittsburgh O'Brien Cooperative Research Center Program
-
批准号:10002325
-
项目类别:
-
资助金额:$120.0万
-
财政年份:2016
-
负责人:Zhou Wang
-
依托单位:
The University of Pittsburgh O'Brien Urology Cooperative Research Center Program
-
批准号:10002341
-
项目类别:
-
资助金额:$43.32万
-
财政年份:2016
-
负责人:Zhou Wang
-
依托单位:
University of Pittsburgh O'Brien Cooperative Research Center Program
-
批准号:9764149
-
项目类别:
-
资助金额:$120.0万
-
财政年份:2016
-
负责人:Zhou Wang
-
依托单位:
Luminal epithelial junctions, polarity, and permeability in BPH pathogenesis
-
批准号:10002344
-
项目类别:
-
资助金额:$21.87万
-
财政年份:2016
-
负责人:Zhou Wang
-
依托单位:
University of Pittsburgh O'Brien Cooperative Research Center Program
-
批准号:9357574
-
项目类别:
-
资助金额:$120.0万
-
财政年份:2016
-
负责人:Zhou Wang
-
依托单位:
Luminal Epithelial Junctions, Polarity, and Permeability in BPH Pathogenesis
-
批准号:9323061
-
项目类别:
-
资助金额:$9.24万
-
财政年份:2016
-
负责人:Zhou Wang
-
依托单位:
Molecular signatures associated with prostatic inflammation in rodent models.
-
批准号:8566145
-
项目类别:
-
资助金额:$24.67万
-
财政年份:2012
-
负责人:Zhou Wang
-
依托单位:
2011 AUA/SBUR Basic Sciences Symposium
-
批准号:8205672
-
项目类别:
-
资助金额:$0.95万
-
财政年份:2011
-
负责人:Zhou Wang
-
依托单位:
University of Pittsburgh Planning Center for Benign Prostate Hyperplasia Research
-
批准号:8049858
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2010
-
负责人:Zhou Wang
-
依托单位:
University of Pittsburgh Planning Center for Benign Prostate Hyperplasia Research
-
批准号:8151009
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2010
-
负责人:Zhou Wang
-
依托单位:
P-1: 5A-Reductase Inhibition in Intermittent Androgen Ablation Therapy in Pros
-
批准号:8055504
-
项目类别:
-
资助金额:$31.19万
-
财政年份:2010
-
负责人:Zhou Wang
-
依托单位:
Molecular signatures associated with prostatic inflammation in rodent models.
-
批准号:8448371
-
项目类别:
-
资助金额:$24.67万
-
财政年份:2010
-
负责人:Zhou Wang
-
依托单位:
5-Alpha-Reductase Inhibition in Intermittent Androgen Ablation Therapy in Prostat
-
批准号:7587123
-
项目类别:
-
资助金额:$32.02万
-
财政年份:2008
-
负责人:Zhou Wang
-
依托单位:
Role of Eaf family proteins in prostate carcinogenesis
-
批准号:7560418
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2007
-
负责人:Zhou Wang
-
依托单位:
Role of Eaf family proteins in prostate carcinogenesis
-
批准号:7365230
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2007
-
负责人:Zhou Wang
-
依托单位:
Role of Eaf family proteins in prostate carcinogenesis
-
批准号:7759157
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2007
-
负责人:Zhou Wang
-
依托单位:
海外基金